Jemma Johns

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 3

Top Topics

Sickle Cell Disease

Low Birth Weight

Randomized Controlled Trial

Top Venues

Health technology assessment (Winchester, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Sivarajini Inparaj, Laura L Oakley, Vicky Robinson, Sarah Brien, Jeannine Marie Joseph, Joseph Sharif, Laura McCabe, Hilary Jane Thompson, Moji Awogbade, Jemma Johns, Denise Menezes Brunetta, Paul T Seed
Prophylactic exchange-transfusion in sickle cell disease pregnancy: TAPS2 feasibility randomized controlled trial. Blood advances (2024)
Sivarajini Inparaj, Laura L Oakley, Vicky Robinson, Sarah Brien, Jeannine Joseph, Joseph Sharif, Laura McCabe, Hilary Thompson, Moji Awogbade, Jemma Johns, Denise Menezes Brunetta, Paul T Seed
Prophylactic exchange transfusion in sickle cell disease pregnancy: a TAPS2 feasibility randomized controlled trial. Blood advances 8 (16) (2024)
Arri Coomarasamy, Hoda M Harb, Adam J Devall, Versha Cheed, Tracy E Roberts, Ilias Goranitis, Chidubem Okeke Ogwulu, Helen Marie Williams, Ioannis D Gallos, Abey Eapen, Jane P Daniels, Amna Ahmed, Ruth Bender Atik, Kalsang Bhatia, Cecilia Bottomley, Jane Brewin, Meenakshi Choudhary, Fiona Crosfill, Shilpa Deb, William Colin Duncan, Andrew K Ewer, Kim Hinshaw, Thomas Holland, Feras Izzat, Jemma Johns, Mary-Ann Lumsden, Padma Manda, Jane E Norman, Natalie Nunes, Caroline E Overton, Kathiuska Kriedt, Siobhan Quenby, Sandhya Rao, Jackie A Ross, Anupama Shahid, Martyn Underwood, Nirmala Vaithilingham, Linda Watkins, Catherine Wykes, Andrew W Horne, Davor Jurkovic, Lee J Middleton
Progesterone to prevent miscarriage in women with early pregnancy bleeding: the PRISM RCT. Health technology assessment (Winchester, England) 24 (33) (2021)